Twist Bioscience Corporation TWST

$ 41.84 1.78%

Annual report 2024
added 11-18-2024

Twist Bioscience Corporation Balance Sheet 2011-2024 | TWST

Annual Balance Sheet Twist Bioscience Corporation

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-141 M	-192 M	-285 M	-406 M	-86.4 M	-39 M	-71 M	-22.1 M	-17.4 M	-	-	-	-	-
Long Term Debt	70.2 M	79.2 M	81.3 M	53.2 M	1.4 M	4.4 M	7.22 M	9.15 M	9.81 M	-	-	-	-	-
Long Term Debt Current	14.8 M	14.9 M	13.6 M	8.21 M	6.41 M	3.33 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	4.56 M	299 M	210 M	144 M	-	-	-	-	-
Total Current Liabilities	71 M	73.3 M	90.7 M	63.1 M	36 M	30.4 M	-	-	-	-	-	-	-	-
Total Liabilities	142 M	153 M	172 M	121 M	62.6 M	34.9 M	317 M	219 M	153 M	-	-	-	-	-
Deferred Revenue	2.13 M	3 M	3.48 M	1.09 M	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.24 B	-1.03 B	-828 M	-611 M	-458 M	-319 M	-211 M	-140 M	-80.3 M	-	-	-	-	-
Total Assets	614 M	776 M	961 M	702 M	399 M	187 M	116 M	85.7 M	76.5 M	-	-	-	-	-
Cash and Cash Equivalents	226 M	286 M	380 M	467 M	94.2 M	46.7 M	80.8 M	31.6 M	-	-	-	-	-	-
Book Value	473 M	623 M	789 M	581 M	336 M	152 M	-201 M	-133 M	-76.6 M	-	-	-	-	-
Total Shareholders Equity	473 M	623 M	789 M	581 M	336 M	152 M	-201 M	-133 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Twist Bioscience Corporation

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	72.6 M	74.8 M	77.1 M	79.2 M	79.9 M	77.8 M	79.7 M	81.3 M	64.2 M	65.5 M	60.3 M	53.2 M	53.8 M	53.2 M	625 K	1.4 M	1.4 M	1.4 M	3.67 M	4.4 M	4.4 M	4.4 M	6.53 M	7.22 M	7.22 M	7.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	147 M	143 M	143 M	153 M	153 M	150 M	164 M	172 M	159 M	158 M	160 M	121 M	115 M	121 M	61.6 M	62.6 M	62.6 M	62.6 M	89.2 M	34.9 M	34.9 M	34.9 M	25.9 M	26.7 M	26.7 M	26.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	2.94 M	2.54 M	2.64 M	3 M	3 M	1.94 M	3.68 M	3.48 M	-	-	-	-	-	600 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.21 B	-1.12 B	-1.08 B	-1.03 B	-987 M	-929 M	-870 M	-828 M	-777 M	-717 M	-656 M	-611 M	-569 M	-611 M	-491 M	-458 M	-458 M	-458 M	-374 M	-319 M	-319 M	-319 M	-233 M	-211 M	-211 M	-211 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	638 M	703 M	733 M	776 M	810 M	854 M	910 M	961 M	980 M	1.02 B	786 M	702 M	725 M	702 M	700 M	399 M	399 M	399 M	192 M	187 M	187 M	187 M	164 M	116 M	116 M	116 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	239 M	243 M	266 M	286 M	312 M	318 M	319 M	379 M	378 M	409 M	193 M	466 M	477 M	466 M	349 M	94.2 M	93.7 M	93.7 M	26 M	46.7 M	46.7 M	46.7 M	66.5 M	80.8 M	80.8 M	80.8 M	26.3 M	31.2 M	-	-	-	29.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	491 M	560 M	590 M	623 M	658 M	704 M	746 M	789 M	821 M	863 M	626 M	581 M	610 M	581 M	638 M	336 M	336 M	336 M	103 M	152 M	152 M	152 M	139 M	89.1 M	89.1 M	89.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	491 M	560 M	590 M	623 M	658 M	704 M	746 M	789 M	821 M	863 M	626 M	581 M	610 M	614 M	638 M	336 M	638 M	638 M	103 M	152 M	103 M	103 M	139 M	-201 M	139 M	139 M	-150 M	-133 M	-	-	-	-76.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency